CompletedNCT00770458

Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

Studying Turner syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sequenom, Inc.
Principal Investigator
Allan Bombard, MD
Sequenom, Inc.
Enrollment
1000 enrolled
Eligibility
18 years · FEMALE
Timeline
20082009

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00770458 on ClinicalTrials.gov

Other trials for Turner syndrome

Additional recruiting or active studies for the same condition.

See all trials for Turner syndrome

← Back to all trials